James Gordon

Stock Analyst at JP Morgan

(2.93)
# 1,590
Out of 4,964 analysts
9
Total ratings
83.33%
Success rate
22.47%
Average return

Stocks Rated by James Gordon

argenx SE
Aug 4, 2025
Maintains: Overweight
Price Target: $775$830
Current: $705.24
Upside: +17.69%
Grifols
Jun 17, 2025
Maintains: Neutral
Price Target: $7.6$10
Current: $9.93
Upside: +3.73%
Genmab
Aug 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $25.12
Upside: -
FibroGen
Apr 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $10.58
Upside: -